Granisetron API is a pharmaceutical-grade 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist widely used to prevent and treat chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and postoperative nausea and vomiting (PONV). It works by selectively blocking serotonin (5-HT3) receptors located in the gastrointestinal tract and central nervous system, thereby preventing nausea and vomiting caused by chemotherapy, radiation therapy, or surgical procedures.
Granisetron is commonly formulated as oral tablets, injectable solutions, transdermal patches, and extended-release formulations. Due to its efficacy, long duration of action, and favorable safety profile, it is extensively used in oncology, anesthesia, and supportive care.
Swapnroop Drugs and Pharmaceuticals manufactures premium-quality Granisetron API under stringent WHO-GMP manufacturing standards. Every batch undergoes comprehensive testing for purity, assay, stability, impurities, and compliance with international pharmacopoeial standards. Complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and technical specifications, is available.
Granisetron API is supplied in pharmaceutical-grade HDPE containers or fiber drums suitable for commercial manufacturing.
The CAS Number of Granisetron API is 109889-09-0.
Granisetron API is used to prevent and treat chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and postoperative nausea and vomiting (PONV).
Granisetron selectively blocks 5-HT3 receptors, preventing serotonin from triggering the vomiting reflex during chemotherapy, radiotherapy, or surgery.
Yes. We provide Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), technical specifications, impurity profiles, and complete regulatory documentation.
Yes. We supply Granisetron API in commercial quantities worldwide with customized packaging and reliable export support.
Get Bulk Quote via WhatsApp